Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Pollack

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Oncogenesis|February 12, 2019
Most canine ameloblastomas harbor HRAS mutations, providing a novel large-animal model of RAS-driven cancerPersiana S Saffari, Natalia Vapniarsky, Anna S Pollack, et al.
Plos One|September 3, 2011
SMURF1 amplification promotes invasiveness in pancreatic cancerKevin A Kwei, A Hunter Shain, Ryan Bair, et al.
The American Journal of Pathology|February 25, 2003
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarrayJohn P T Higgins, Rajesh Shinghal, Harcharan Gill, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2002
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumorsJonathan R Pollack, Therese Sørlie, Charles M Perou, et al.
The American Journal of Surgical Pathology|January 3, 2020
Gene Expression Profiling of Head and Neck Tumors Identifies FOXP1 and SOX10 Expression as Useful for Distinguishing Ameloblastoma From Basaloid Salivary Gland TumorsYen Chen Kevin Ko, Sushama Varma, Chun Fang Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
CDX2 is an amplified lineage-survival oncogene in colorectal cancerKeyan Salari, Mary E Spulak, Justin Cuff, et al.
Haematologica|October 15, 2020
The long non-coding RNA <i>Cancer Susceptibility 15</i> (<i>CASC15</i>) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemiaSarah Grasedieck, Christoph Ruess, Kathrin Krowiorz, et al.
Haematologica|December 2, 2021
The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangementsSarah Grasedieck, Ariene Cabantog, Liam MacPhee, et al.
Plos One|July 8, 2009
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discoveryJessica Kao, Keyan Salari, Melanie Bocanegra, et al.
The Journal of Clinical Investigation|April 3, 2025
Immune repertoire profiling uncovers pervasive T cell clonal expansions in benign prostatic hyperplasiaAnna S Pollack, Christian A Kunder, Chandler C Ho, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Oncogenesis|February 12, 2019
Most canine ameloblastomas harbor HRAS mutations, providing a novel large-animal model of RAS-driven cancerPersiana S Saffari, Natalia Vapniarsky, Anna S Pollack, et al.
Plos One|September 3, 2011
SMURF1 amplification promotes invasiveness in pancreatic cancerKevin A Kwei, A Hunter Shain, Ryan Bair, et al.
The American Journal of Pathology|February 25, 2003
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarrayJohn P T Higgins, Rajesh Shinghal, Harcharan Gill, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2002
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumorsJonathan R Pollack, Therese Sørlie, Charles M Perou, et al.
The American Journal of Surgical Pathology|January 3, 2020
Gene Expression Profiling of Head and Neck Tumors Identifies FOXP1 and SOX10 Expression as Useful for Distinguishing Ameloblastoma From Basaloid Salivary Gland TumorsYen Chen Kevin Ko, Sushama Varma, Chun Fang Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
CDX2 is an amplified lineage-survival oncogene in colorectal cancerKeyan Salari, Mary E Spulak, Justin Cuff, et al.
Haematologica|October 15, 2020
The long non-coding RNA <i>Cancer Susceptibility 15</i> (<i>CASC15</i>) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemiaSarah Grasedieck, Christoph Ruess, Kathrin Krowiorz, et al.
Haematologica|December 2, 2021
The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangementsSarah Grasedieck, Ariene Cabantog, Liam MacPhee, et al.
Plos One|July 8, 2009
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discoveryJessica Kao, Keyan Salari, Melanie Bocanegra, et al.
The Journal of Clinical Investigation|April 3, 2025
Immune repertoire profiling uncovers pervasive T cell clonal expansions in benign prostatic hyperplasiaAnna S Pollack, Christian A Kunder, Chandler C Ho, et al.
Pageof 10